| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.3 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.3 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |